Medicines for Europe

🗣️ Today, we had the opportunity to speak at the Greener Pharma Supply Chain online workshop organised by Health Care Without Harm Europe. 🌱Lina Andersson, Head of Global Sustainability at Viatris, represented our Sustainability committee, highlighting the off patent medicines industry’s commitment to sustainable manufacturing and supply chains. We are proud to contribute to a more resilient future for healthcare by: 💊 Providing affordable access to essential medicines to patients ⛓️ Delivering on our environmental commitments while safeguarding resilient medicines supply 💡 Investing in both supply reliability and environmental stewardship Big thanks to the organisers for the insightful workshop! #HCWH #MedicinesForEurope #Sustainability #Access4All

🔗 Digitalisation in healthcare is more than a trend. We promote a #LevellingUp in healthcare: smarter, more efficient, and more connected than ever.

🌟 The EU must do more to support affordable innovation by creating a framework for value added and repurposed medicines, which can bring new treatment opportunities to patients.

📈 The EU should support off-patent medicine manufacturing, aiming for a competitive, greener future with enhanced strategic autonomy in healthcare. To deliver on this, we are calling for a Critical Medicines Act in the first 100 days of office of the new EU mandate #LevellingUp #EquitableAccess

📣 We are thrilled to announce our panel on Access to Europe’s Critical Medicines at the upcoming European Health Forum Gastein, 26 September, in collaboration with Viatris. Join us as we explore supply chain resilience strategies and patient access as key foundations of the future #CriticalMedsAct. 📅 Date: September 26 🕒 Time: 16:15 – 17:30 We look forward to an interactive discussion with experts, policymakers and industry peers on medicines security. 👉 Don't miss out! Register now to be part of the event in person or online: https://rb.gy/pl4vzv #EHFG2024 #CriticalMeds #SecurityOfSupply #Access4all

🙌 We are ready to lead a health revolution with a digital framework that ensures equitable access, harmonisation and sustainability. Read more in our EU manifesto at https://buff.ly/4g6OJJv

🔄 Off-patent innovation, timely competition and transparent supply chains can drive us towards a future where no patient is left behind.

Thank you Oriol Güell for your interview at the Medicines for Europe Conference. A great opportunity to highlight the need for better medicines procurement policies in Europe as well as price review mechanisms for lower-priced medicines. Let’s cross our fingers new measures help ensuring supply of critical (and usually old) medicines, but as important for the patient as the newer ones. #genericdrugs #europe #medicinesforeurope

💡Access to essential generic and biosimilar medicines is vital for patients. As a new European mandate begins, Medicines for Europe is ready to build a sustainable future based on equity, timely competition and security. #LevellingUp #Access #EUPharmaStrategy #TogetherforHealth

💊 🏥 Do you want to play an important role in ensuring access to off-patent medicines in Europe? Then you might be interested in applying to be a Market Access Policy Officer in our team! 🔍 See more details in the vacancy below, including details how to apply. Good luck! ☘ #hiring #vacancy #EUjobs https://lnkd.in/g5S7SzSc